Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.
about
Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemicGenetic background in nonalcoholic fatty liver disease: A comprehensive reviewLeptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individualsWhat are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease.Fatty pancreas, insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging.Major Components of Metabolic Parameters and Nutritional Intakes in Different Genotypes of Adiponectin +276 G>T Gene Polymorphism in Non-Diabetes and Non-Alcoholic Iranian Fatty Liver Patients.Pinus densiflora Sieb. et Zucc. alleviates lipogenesis and oxidative stress during oleic acid-induced steatosis in HepG2 cells.Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease in a hospital cohort and its association with anthropometric, biochemical and sonographic characteristics.Association between nonalcoholic fatty liver disease and colorectal adenoma: a systemic review and meta-analysisAdipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitisHigher estimated net endogenous Acid production may be associated with increased prevalence of nonalcoholic Fatty liver disease in chinese adults in Hong Kong.High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial.Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia.The relationship between nonalcoholic fatty liver disease and colorectal cancer: the future challenges and outcomes of the metabolic syndrome.Current concepts in the pathogenesis of nonalcoholic fatty liver disease.How should we manage patients with non-alcoholic fatty liver disease in 2007?Effects of metabolic syndrome on fibrosis in chronic viral hepatitisAssociation of Adiponectin rs1501299 and rs266729 Gene Polymorphisms With Nonalcoholic Fatty Liver Disease.Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy.The relationship of nonalcoholic fatty liver disease and metabolic syndrome for colonoscopy colorectal neoplasm.Fatty liver in childhood.Nonalcoholic steatohepatitis: risk factors and diagnosis.Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.Association of tumor necrosis factor-α gene promoter polymorphism at sites -308 and -238 with non-alcoholic fatty liver disease: a meta-analysis.Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease.Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.Nonalcoholic fatty liver disease - current status and future directions.Association of recently described adipokines with liver histology in biopsy-proven non-alcoholic fatty liver disease: a systematic review.Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells.Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients.Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines.Non-alcoholic fatty liver diseases and risk of colorectal neoplasia.Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study.Bacterial endotoxin and non-alcoholic fatty liver disease in the general population: a prospective cohort study.Sex-influenced association of non-alcoholic fatty liver disease with colorectal adenomatous and hyperplastic polyps.Risk of Colorectal Neoplasia According to Fatty Liver Severity and Presence of Gall Bladder Polyps.
P2860
Q24563381-3260AE37-8398-4358-ADF0-1B05FC91C61DQ26780248-C2793411-07D8-464A-9CA9-EC2C9C993180Q26859118-5887CD98-2340-48BD-AE66-BF5E0005AF19Q30361645-3C8BB436-A0A2-40FB-8873-096109F3BAF6Q30435948-6CC61388-6609-4014-BFA6-A350701F057CQ30747665-A718CB8C-AB8A-42C3-B234-0818F5EEF6C8Q33883038-3D58713B-57C9-401C-AD1A-B0F8D8AD8A82Q33963339-72DE3B61-466D-4267-8C30-CEAD4566BBA8Q34091040-55060B7F-DD88-4638-B32F-70599E8F11A3Q34484320-6CEB5F49-C776-40DE-AD95-5CEEE5157280Q34779049-65E575F0-75C9-4280-87FA-AFC215373994Q35100100-9EA2C2A8-AAEF-4C84-9127-41E4C396F414Q35532673-61D45704-E67D-452C-B006-1020F8FE8004Q35683422-834CD023-AEEB-4604-94A8-A5D93BD8471DQ35788887-E689CB90-9425-4231-9C40-124D3137ECC8Q36405031-E207C13A-A70E-42DA-9A3C-A3AF85D93CCEQ36470460-8543FE77-6670-4DA2-9523-B76600C9BFB2Q36777932-73A3D0A8-42C2-46BE-A258-620CF2ED287CQ36848280-CD3EB21F-2559-4995-91F3-46D399EC7DA4Q37046576-4B7A97F0-5C4F-413A-8B40-2997FDD8A93AQ37073866-91403245-DFFD-4A7D-B19F-2012D2049A29Q37596984-FD516782-3293-438E-ABB2-2FC6888C50F7Q37606349-DA7B83C0-A6E0-4ADD-9E90-48403316F0C5Q37636566-95DC67AE-D4FA-4454-B25F-6BDE10AEA87EQ37798824-3B2752DF-083F-49FC-AB46-F04E70BCC0B5Q37811071-3880ED7B-E42C-478A-866A-260FC8FBB169Q37957955-E5854632-7FA7-4479-B9A1-E0BE6C48F3F0Q38071935-BEA434F2-176B-41BE-AB6F-D9A591F2A1E0Q38128548-B05D8981-1E78-4463-86B0-3F7346FF7175Q38204970-FD573D0A-DFC4-4B5B-8177-24E5FFA31DDAQ38592767-8336457E-B3E7-4BAA-A41A-F670B14ADDDBQ38644618-1A9205CA-57DB-47BC-AC73-15C78C79E204Q39208263-21EE16EB-4524-486E-976A-7C7DE5567DDAQ39658315-52133E2F-217A-405E-B2A5-AB18DD7B7972Q39800763-639E640A-495E-421B-8928-BA956FC2D494Q40470046-2BCDEACF-3C87-41C6-AFC3-95943D92953BQ40501773-C2D6D50D-E86E-47CF-BA99-7C28F86A3648Q40705552-5B1ABC87-2832-444E-9005-847CF1A085A4Q41191108-958F8B5C-F372-48BB-94F5-2718CC87D508Q41345966-7D8E062A-49AB-4549-A0F6-A2B9C296EF20
P2860
Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Metabolic and adipokine profil ...... alcoholic fatty liver disease.
@en
Metabolic and adipokine profil ...... alcoholic fatty liver disease.
@nl
type
label
Metabolic and adipokine profil ...... alcoholic fatty liver disease.
@en
Metabolic and adipokine profil ...... alcoholic fatty liver disease.
@nl
prefLabel
Metabolic and adipokine profil ...... alcoholic fatty liver disease.
@en
Metabolic and adipokine profil ...... alcoholic fatty liver disease.
@nl
P2093
P1476
Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease
@en
P2093
Ada Mei-Ling Tse
Alex Yui Hui
Angela Yuen-Shan Cheng
Grace Lai-Hung Wong
Henry Lik-Yuen Chan
Joyce Lai-Yee Chan
Kui-Fat Chan
Steven Woon-Choy Tsang
Vincent Wai-Sun Wong
Wing-Fung Ng
P304
P356
10.1016/J.CGH.2006.06.011
P407
P577
2006-08-14T00:00:00Z